MAPLE SYRUP URINE DISEASE FAMILY SUPPORT GROUP INC (EIN 541556981) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

DAVID BULCHER

Phone

7409725618

Tax Period

2023-01-01 to 2023-12-31

MAPLE SYRUP URINE DISEASE FAMILY SUPPORT GROUP INC, founded in 1990, is a micro nonprofit that reported $67K in total revenue in fiscal year 2023. Revenue surged 153% from the prior year, signaling strong growth momentum. The organization ran a surplus of $14K, a strong 21% operating margin.

Mission

DISSEMINATE INFORMATION AND SUPPORT RESEARCH ON MAPLE SYRUP URINE DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $42,637

Program Service Revenue $9,961

Investment Income $47

Other Revenue $14,595

TOTAL REVENUE $67,240

Expense Breakdown

Grants Paid $0

Salaries & Benefits $22,913

Fundraising Expenses $1,126

Program Expenses $48,909

Other Expenses $30,531

TOTAL EXPENSES $53,444

Year-over-Year Comparison

	2023	2022	Change
Revenue	$67,240	$26,625	+1.5%
Expenses	$53,444	$31,429	+0.7%
Net Income	$13,796	$-4,804	-3.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$21,285

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JORDANN COLEMAN	TRUSTEE	1.00	Director	$0	$0	$0
HERB FOSTER	TRUSTEE	1.00	Director	$0	$0	$0
DAVID BULCHER	TREASURER	1.00	Officer Director	$0	$0	$0
IVAN MARTIN	TRUSTEE	1.00	Director	$0	$0	$0
SANDY BULCHER	PRESIDENT	1.00	Officer Director	$0	$0	$0
KAREN DOLINS	SECRETARY	1.00	Officer Director	$0	$0	$0
EDWARD FISCHLER	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
DENISE KOLIVOSKI	EXECUTIVE DIRECTOR	40.00	Director	$21,285	$0	$21,285

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$67,240	$53,444	$558,525	$13,796
2022	$26,625	$31,429	$544,729	$-4,804
2021	$64,988	$17,760	$549,533	$47,228
2020	$8,437	$56,698	$502,305	$-48,261
2019	$83,425	$22,812	$550,565	$60,613
2018	$49,503	$66,535	$489,952	$-17,032

MAPLE SYRUP URINE DISEASE FAMILY SUPPORT GROUP INC